Frederiks, Charlotte N.
Overwater, Anouk
Bergman, Jacques J. G. H. M.
Pouw, Roos E.
de Keizer, Bart
Bennink, Roel J.
Brosens, Lodewijk A. A.
Meijer, Sybren L.
van Hillegersberg, Richard
van Berge Henegouwen, Mark I.
Ruurda, Jelle P.
Gisbertz, Suzanne S.
Weusten, Bas L. A. M.
Funding for this research was provided by:
Dutch Cancer Society (Project number 10944)
Article History
Received: 28 November 2022
Accepted: 16 February 2023
First Online: 23 March 2023
Disclosure
: C.N. Frederiks has received speaker’s fee from Pentax Medical. J.J.G.H.M. Bergman is a consultant for Boston Scientific, Cook Medical and Medtronic, and has received research funding from Aqua Medical, Fuji Film, Olympus Endoscopy, Pentax Medical and Medtronic. R. van Hillegersberg is a consultant for Intuitive Surgical and Medtronic. J.P. Ruurda is a consultant for Intuitive Surgical. M.I. van Berge Henegouwen is a consultant for Alesi Surgical, BBraun, Johnson & Johnson, Medtronic and Viatris, and has received research funding from Stryker. B.L.A.M. Weusten is a consultant for Pentax Medical, has received speaker’s fee from Pentax Medical, and has received research funding from Aqua Medical and Pentax Medical. The remaining authors have no disclosures to declare relevant to this manuscript.